Amplifon schedules October 29 results and analysts target Amplifon stock at EUR 13.63

Published on 10/23/2026 at 10:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Amplifon stock costs EUR 12.84 on October 23, 2026 against a EUR 13.63 target. Third-quarter results are due October 29.

Results date and valuation

Amplifon will publish third-quarter results on October 29, 2026.
First-half 2026 revenue reached EUR 1.19 billion, up 1.30 percent at constant exchange rates.
Amplifon stock trades at EUR 12.84 at 10:02 a.m. CEST at Lang & Schwarz on October 23, 2026.

Farbenfrohe Pop-Art-Comicillustration einer Hörtest-Szene mit Halftone-Muster — Pop-Art-Comicszene mit Hörtest-Motiv visualisiert farbenfroh die Branche von Amplifon S.p.A., ISIN IT0004056880, Gesundheitswesen, Illustration mit AI erstellt.

Amplifon stock (ISIN IT0004056880) has an average analyst target of EUR 13.63 ahead of the company's October 29, 2026 third-quarter results, according to MarketScreener. The date gives investors a defined test for the recovery in growth and profitability reported during the first half.

Margins set the first test

Amplifon reported first-half 2026 revenue of EUR 1.19 billion, up 1.30 percent at constant exchange rates, while organic growth reached 3.50 percent, according to Rankia. Second-quarter organic growth accelerated to 4.70 percent, the strongest pace in two years, and adjusted EBITDA for the half reached EUR 298.00 million, up 3.60 percent.

The adjusted EBITDA margin rose to 25.10 percent, an increase of 0.70 percentage points, while second-quarter adjusted EBITDA increased 6.10 percent. Management maintained its full-year 2026 outlook for organic growth above 3.00 percent and an adjusted EBITDA margin increase of about 1.00 percentage point, as reported by Rankia.

What does the October date mean?

The October 29 agenda combines the third-quarter results with a shareholder meeting linked to the planned GN Hearing transaction. The acquisition is valued at EUR 2.30 billion on a cash-and-debt-free basis, with EUR 1.69 billion in cash and 56 million new Amplifon shares due to GN Store Nord at closing, according to Rankia.

Three milestones frame the deal

Amplifon announced the GN Hearing agreement on March 16, 2026, with a EUR 2.30 billion transaction value. On May 22, 2026, it placed 45.30 million new shares at EUR 10.00 each and raised EUR 453.00 million. On October 9, 2026, Morgan Stanley lifted its target from EUR 14.90 to EUR 14.96 and retained an Overweight rating, reported by Repubblica.

Stock price and investor dates

Morningstar wrote on October 21, 2026, that Amplifon's second-quarter results showed organic growth and expanding EBITDA margins. It also identified the ended US managed-care agreement as a counter-factor and placed fair value at EUR 11.70.

Amplifon was trading at EUR 12.84 at Lang & Schwarz on October 23, 2026 at 10:02 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Amplifon stock.